Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Fulcrum Therapeutics Inc (NQ: FULC ) 8.880 +0.240 (+2.78%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 413,299 Open 8.850 Bid (Size) 7.700 (1) Ask (Size) 9.180 (10) Prev. Close 8.640 Today's Range 8.650 - 9.300 52wk Range 3.140 - 13.70 Shares Outstanding 61,758,994 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Fulcrum Therapeutics to Host Second Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, July 31, 2024, at 8:00 a.m. ET July 24, 2024 From Fulcrum Therapeutics, Inc. Via GlobeNewswire Top 3 Health Care Stocks That Should Keep You Up At Night This Quarter July 16, 2024 Via Benzinga Performance YTD +23.16% +23.16% 1 Month +43.92% +43.92% 3 Month +24.37% +24.37% 6 Month +27.77% +27.77% 1 Year +150.85% +150.85% More News Read More Fulcrum Therapeutics to Present at the 31st Annual FSHD Society International Research Congress June 12, 2024 From Fulcrum Therapeutics, Inc. Via GlobeNewswire Deep Dive Into Fulcrum Therapeutics Stock: Analyst Perspectives (4 Ratings) May 13, 2024 Via Benzinga Fulcrum Therapeutics Inc. (NASDAQ: FULC) is a Stock Spotlight on 4/12 April 12, 2024 Via Investor Brand Network Fulcrum Therapeutics Inc. (NASDAQ: FULC) is a Stock Spotlight on 3/6 March 06, 2024 Via Investor Brand Network 10 Health Care Stocks With Whale Alerts In Today's Session June 11, 2024 Via Benzinga Fulcrum Therapeutics to Participate in the Goldman Sachs’ 45th Annual Global Healthcare Conference June 06, 2024 From Fulcrum Therapeutics, Inc. Via GlobeNewswire FULC Stock Earnings: Fulcrum Therapeutics Beats EPS for Q1 2024 May 13, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Monday's Pre-Market Session May 13, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday May 13, 2024 Via InvestorPlace Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2024 May 13, 2024 From Fulcrum Therapeutics, Inc. Via GlobeNewswire Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Development and Commercialization of Losmapimod in Facioscapulohumeral Muscular Dystrophy May 13, 2024 From Fulcrum Therapeutics, Inc. Via GlobeNewswire Fulcrum Therapeutics to Participate in Upcoming May Conferences May 09, 2024 From Fulcrum Therapeutics, Inc. Via GlobeNewswire Fulcrum Therapeutics Announces Publication of Results from Phase 2b Clinical Trial of Losmapimod in Facioscapulohumeral muscular dystrophy (ReDUX4) in The Lancet Neurology May 08, 2024 From Fulcrum Therapeutics, Inc. Via GlobeNewswire Fulcrum Therapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Monday, May 13, 2024, at 8:00 a.m. ET May 06, 2024 From Fulcrum Therapeutics, Inc. Via GlobeNewswire Biotech on a Budget: 7 Stocks Under $10 With Huge Potential April 15, 2024 Via InvestorPlace 10 Health Care Stocks Whale Activity In Today's Session March 29, 2024 Via Benzinga Fulcrum Therapeutics to Participate at the Cantor Virtual Muscular Dystrophy Symposium March 28, 2024 From Fulcrum Therapeutics, Inc. Via GlobeNewswire Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 22, 2024 From Fulcrum Therapeutics, Inc. Via GlobeNewswire Fulcrum Therapeutics Appoints Patrick Horn M.D., Ph.D., as Chief Medical Officer March 18, 2024 From Fulcrum Therapeutics, Inc. Via GlobeNewswire Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 08, 2024 From Fulcrum Therapeutics, Inc. Via GlobeNewswire Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday March 06, 2024 Via Benzinga Topics Stocks Exposures US Equities Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session March 06, 2024 Via Benzinga Fulcrum Therapeutics to Participate at the Leerink Partners Global Biopharma Conference March 05, 2024 From Fulcrum Therapeutics, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.